SIMI, LISA
 Distribuzione geografica
Continente #
NA - Nord America 4.926
EU - Europa 3.542
AS - Asia 1.539
SA - Sud America 176
Continente sconosciuto - Info sul continente non disponibili 52
AF - Africa 41
OC - Oceania 31
Totale 10.307
Nazione #
US - Stati Uniti d'America 4.845
PL - Polonia 1.257
RU - Federazione Russa 814
IT - Italia 584
SG - Singapore 457
CN - Cina 334
HK - Hong Kong 239
IE - Irlanda 185
SE - Svezia 176
VN - Vietnam 150
DE - Germania 141
BR - Brasile 135
KR - Corea 106
FI - Finlandia 82
IN - India 71
UA - Ucraina 71
FR - Francia 66
CH - Svizzera 58
JO - Giordania 47
GB - Regno Unito 41
CA - Canada 39
AU - Australia 30
NL - Olanda 25
TR - Turchia 24
BD - Bangladesh 21
ID - Indonesia 19
MX - Messico 18
IQ - Iraq 15
AR - Argentina 13
AT - Austria 12
JP - Giappone 12
BE - Belgio 10
EC - Ecuador 10
CI - Costa d'Avorio 9
ES - Italia 8
VE - Venezuela 7
JM - Giamaica 6
NG - Nigeria 6
PH - Filippine 6
PK - Pakistan 6
UZ - Uzbekistan 6
SA - Arabia Saudita 5
CL - Cile 4
DZ - Algeria 4
KE - Kenya 4
NP - Nepal 4
TW - Taiwan 4
CO - Colombia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
LT - Lituania 3
MA - Marocco 3
NI - Nicaragua 3
OM - Oman 3
RO - Romania 3
SC - Seychelles 3
ZA - Sudafrica 3
AL - Albania 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
IL - Israele 2
MY - Malesia 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
BJ - Benin 1
BO - Bolivia 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BY - Bielorussia 1
EE - Estonia 1
EU - Europa 1
GD - Grenada 1
GT - Guatemala 1
IR - Iran 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
RE - Reunion 1
SV - El Salvador 1
TG - Togo 1
TN - Tunisia 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
Totale 10.257
Città #
Warsaw 1.255
Santa Clara 844
Ashburn 602
Fairfield 432
Singapore 290
Chandler 284
San Jose 220
Hong Kong 196
Woodbridge 196
Seattle 192
Dublin 185
Cambridge 162
Houston 156
Wilmington 142
Jacksonville 114
Milan 106
Seoul 105
Beijing 103
Dallas 89
Florence 80
Ann Arbor 71
Council Bluffs 69
Altamura 62
Lawrence 60
Los Angeles 55
Bern 54
Princeton 52
New York 46
Buffalo 44
Boardman 42
Ho Chi Minh City 42
Lauterbourg 42
The Dalles 37
Boston 36
Munich 36
Rome 35
Hefei 33
Phoenix 30
Shanghai 30
Melbourne 29
Mumbai 29
Kent 25
Hanoi 23
Medford 22
San Diego 22
Bremen 21
Helsinki 20
Dong Ket 19
Turku 18
Pune 17
Moscow 16
Frankfurt am Main 15
Izmir 13
Jakarta 13
Orem 13
Chicago 12
Vienna 12
Columbus 11
São Paulo 11
Tokyo 11
Turin 11
Brussels 10
Yubileyny 10
Abidjan 9
Clifton 9
Falls Church 9
Naples 9
Norwalk 9
Paris 9
Amsterdam 7
Chennai 7
Montreal 7
Redondo Beach 7
Stockholm 7
Genoa 6
Hillsboro 6
London 6
Palermo 6
Redwood City 6
Rio de Janeiro 6
Springfield 6
Toronto 6
Verona 6
Abuja 5
Arezzo 5
Baghdad 5
Brescia 5
Brooklyn 5
Figino 5
Philadelphia 5
Salvador 5
San Antonio 5
San Francisco 5
Tashkent 5
Andover 4
Ankara 4
Auburn Hills 4
Barcelona 4
Catania 4
Denver 4
Totale 7.254
Nome #
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers 445
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer. 357
Seladin-1 expression is regulated by promoter methylation inadrenal cancer 331
Influence of 17q gain and promoter polymorphisms on mRNA expression of somatostatin receptor type 2 in neuroblastoma. 319
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer 310
Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR. 294
SPIDIA-DNA: an External Quality Assessment for the pre-analytical phase of blood samples used for DNA-based analyses. 293
KIT genetic alterations in anorectal melanomas. 282
SPIDIA-RNA: second external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. 271
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. 250
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 246
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 233
An Italian Program of External Quality Control for Quantitative Assays Based on Real-Time PCR with Taq-Man Probes. 228
GM1 gangliosidosis: molecular analysis of nine patients and development of an RT-PCR assay for GLB1 gene expression profiling. 224
Analytical evaluation of an NGS testing method for routine molecular diagnostics on melanoma formalin-fixed, paraffin-embedded tumor-derived DNA 220
Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer. 215
Monitoring the susceptibility to oseltamivir of Influenza A(H1N1) 2009 virus by nested-PCR and pyrosequencing during the pandemic and in the season 2010-2011. 215
Denosumab treated giant cell tumour of bone: A morphological, immunohistochemical and molecular analysis of a series 215
Expression of uteroglobin and matrix metalloproteinase-9 genes in endometrial cancer: relationship to estrogen and progesterone receptor status. 201
Atypical Spitzoid melanocytic tumors: a morphological,mutational, and FISH analysis 198
null 196
SPIDIA-RNA: First external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. 196
Histone 3.3 mutations in giant cell tumor and giant cell-rich sarcomas of bone. 191
Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations 190
SDH mutations in patients affected by paraganglioma syndromes: a personal experience. 189
Phenotype variability of neural crest-derived tumours in six Italian families segregating the same founder SDHD mutation Q109X. 187
Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer. 187
Immunohistochemistry is highly sensitive and specific for the detection of NRASQ61R mutation in melanoma. 187
Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. 185
The use of COLD-PCR and High Resolution Melting Analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer 185
Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis. 183
Antineoplastic effects of rosiglitazone and PPARgamma transactivation in neuroblastoma cells 180
Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. 178
BRAFV600E detection in melanoma is highlyimproved by COLD-PCR. 177
Clodronate acts on human osteoclastic cell proliferation, differentiation and function in a bioreversible manner 175
Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue 172
The clinical role of PIK3CA mutations in colorectal cancer 171
Implementation of a companion diagnostic in the clinical laboratory: The BRAF example in melanoma 170
Clodronate modulates osteoclastogenesis by ATP analog, adenosine 5-(b,g-dichloromethylene) triphosphate, in human cell of the osteoclastic lineage with no toxic 169
BRAF and KIT somatic mutations are present in amelanotic melanoma. 168
Unbalanced GLA mRNAs ratio quantified by real-time PCR in Fabry patients' fibroblasts results in Fabry disease. 166
Protective effect of TGFß3 on the irradiated small instestine of mice. 164
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients 146
Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI. 143
From clinical trials to clinical practice: predictors ofresponse to erlotinib in advanced non-small cell lung cancer patients pretreated with chemotherapy 140
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. 138
The use of COLD-PCR and high-resolution melting analysis improbe the limito f detection of KRAS and BRAF mutations in colorectal cancer 124
Uterine leiomyosarcomas express KIT protein but lack mutation(s) in exon 9 ofc-KIT. 121
Two novel H-RAS mutations identified in a child with anatypical spitzoid tumor. 94
From clinical trials to clinical practice: predictors of response to erlotinib in advanced non-small cell lung cancer patients pretreated with chemotherapy. 88
Totale 10.307
Categoria #
all - tutte 27.123
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.123


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022312 0 0 49 5 14 20 17 18 21 13 65 90
2022/20231.077 81 210 42 111 76 182 116 53 109 4 24 69
2023/2024394 6 38 54 9 27 74 26 117 3 1 30 9
2024/20252.214 59 237 115 378 712 295 18 114 106 49 79 52
2025/20262.589 286 296 191 140 287 102 351 153 168 198 83 334
2026/2027410 82 102 226 0 0 0 0 0 0 0 0 0
Totale 10.307